C07C 255/36
The carbon skeleton being further substituted by hydroxy groups
Official title: the carbon skeleton being further substituted by hydroxy groups
C07C255/36 (The carbon skeleton being further substituted by hydroxy groups) appears on 81 US grants and 51 published applications in this corpus.
Search patents in C07C- Granted patents
- 81
- Published applications
- 51
- Assignees
- 74
- Inventors
- 250
- Latest grant
- 11 Apr 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 6 | 0 |
| 1998 | 10 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 9 | 2 |
| 2002 | 2 | 6 |
| 2003 | 5 | 3 |
| 2004 | 3 | 5 |
| 2005 | 1 | 6 |
| 2006 | 0 | 1 |
| 2007 | 2 | 1 |
| 2008 | 2 | 3 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 2 | 1 |
| 2012 | 2 | 4 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 2 | 2 |
| 2016 | 3 | 3 |
| 2017 | 3 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Estrogen receptor ligands, compositions and methods related thereto11 Apr 2023US 11,622,954 B2The Regents of the University of California
- Method for directly constructing highly optically active tetrasubstituted allenic acid compounds11 Apr 2023US 11,623,907 B2Fudan Univeristy
- Estrogen receptor ligands, compositions and methods related thereto20 Apr 2021US 10,980,767 B2The Regents of the University of California
- Substituted 5-hydroxy-2,3-diphenylpentanonitrile derivatives, processes for their preparation and their use as herbicides and/or plant growth regulators17 Jul 2018US 10,021,877 B2Bayer CropScience AG
- Triphenylethylene compounds and uses thereof19 Dec 2017US 9,845,295 B2Purdue Research Foundation
- Compounds for use as medicaments23 Apr 2026US 2026/0109664 A1Chariot Innovations Ltd
- Phenol derivatives for use as antimicrobial, antibacterial, bactericide5 Feb 2026US 2026/0035353 A1Special Product's Line S.P.A.
- Rescorcinols, methods for their manufacture, and uses thereof1 Aug 2024US 2024/0254066 A1
- Phenol derivatives for use as antimicrobial, antibacterial, bactericide8 Sep 2022US 2022/0281835 A1Special Product's Line S.P.A.
- A method for directly constructing highly optically active tetrasubstituted allenic acid compounds3 Mar 2022US 2022/0064096 A1Fudan University
Most cited
By later US patents
- Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents217US 5,688,819 AAllergan, Inc. · 1997
- Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents177US 6,403,649 B1Allergan Sales, Inc. · 2002
- Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents111US 5,352,708 AAllergan, Inc. · 1994
- Methods and compositions for inhibiting cell proliferative disorders109US 5,789,427 ASugen, Inc. · 1998
- FLK-1 is a receptor for vascular endothelial growth factor90US 5,851,999 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1998